Brainomix secures fresh funding to fuel US expansion
Oxford-based medtech spinout Brainomix has raised an additional £4.8 million to accelerate the rollout of its AI healthtech platform in the United States, as demand grows for faster and more accurate stroke diagnosis in hospitals worldwide.
Founded out of the University of Oxford, Brainomix specialises in AI-powered medical imaging for stroke and other neurological conditions. Its flagship software, widely deployed across European stroke networks, automatically analyses brain scans to support clinicians in making rapid treatment decisions, particularly in emergency settings where every minute can determine patient outcomes.
Targeting US hospitals and stroke networks
The new £4.8 million injection will be used to navigate the complex US regulatory landscape, expand commercial teams, and build partnerships with major hospital systems and integrated stroke networks. The company aims to secure broader adoption of its clinical decision support tools, positioning its platform as a standard component of acute stroke care pathways.
Management has signalled that a significant share of the capital will go toward clinical validation and real-world evidence generation, strengthening the case for payers and providers to adopt AI diagnostics at scale. This includes building datasets that demonstrate improved door-to-needle times, better patient outcomes, and reduced costs for health systems.
Scaling AI healthtech beyond stroke
While stroke remains its core focus, Brainomix is also developing applications in other disease areas where imaging plays a central role, such as lung disease and oncology. The company’s underlying AI algorithms and image-analysis infrastructure are designed to be extensible, allowing new clinical modules to be added over time.
The latest funding round underscores investor confidence in AI healthtech as a critical enabler of more efficient, data-driven healthcare. As US hospitals grapple with staff shortages and rising demand for specialist expertise, tools like those from Brainomix are being positioned as essential infrastructure, not optional add-ons.